Notably, while Nvidia has had a commercial presence in the U.K. for decades, it has amped up its number of strategic programs in the island nation by quite a bit in recent years. Perhaps the most noteworthy among them occurred when Nvidia announced and funded Cambridge-1, touted to be the U.K.’s most powerful supercomputer. Aimed at AI research in healthcare and life sciences, Cambridge-1 was launched in mid-2021 with founding partners that included British pharma giants such as AstraZeneca (AZN), GlaxoSmit ...